TCF7L2 and diabetes mellitus: The dysfunction of TCF7L2 influences the progress of DM through altering insulinotropic hormone glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) secretion or through a defective or dysfunctional GLP-1 and GIP induced insulin secretion [37].